HomePHIO • NASDAQ
add
Phio Pharmaceuticals Corp
Previous close
$1.69
Day range
$4.11 - $9.79
Year range
$1.53 - $10.35
Market cap
12.28M USD
Avg Volume
673.32K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 946.00K | -2.27% |
Net income | -1.52M | 45.18% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.59M | 42.41% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.39M | -35.89% |
Total assets | 5.86M | -38.52% |
Total liabilities | 919.00K | -60.49% |
Total equity | 4.95M | — |
Shares outstanding | 1.06M | — |
Price to book | 0.33 | — |
Return on assets | -71.23% | — |
Return on capital | -91.18% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.52M | 45.18% |
Cash from operations | -1.95M | 32.66% |
Cash from investing | — | — |
Cash from financing | 2.64M | — |
Net change in cash | 692.00K | 123.86% |
Free cash flow | -1.43M | 21.83% |
About
Phio Pharmaceuticals Inc. is a US biotechnology company focused on the field of siRNA. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018. Wikipedia
Founded
2011
Headquarters
Website
Employees
9
